Brind.

Alkem Laboratories Announces Resignation of CFO Amid Strategic Mandates

2 reports, 2 independent Updated Sat 00:00
No new developments lately
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Alkem Laboratories announced the resignation of Nitin Agrawal, its Chief Financial Officer and Key Managerial Personnel, in an exchange filing on September 24, 2026. Agrawal had resigned from the post on July 30, 2026, to pursue new professional opportunities. He thanked the company's Board of Directors for entrusting him with strategic mandates, including building the MedTech business from the ground up and leading various acquisitions.

From moneycontrol.com

Why it matters

Some supportBrind's analysis of the reports

The resignation of the CFO comes as he was involved in major strategic projects, such as the formation of a Saudi joint venture and the acquisition of Oculotech. His tenure involved leading the development of the MedTech business unit and supporting the liquidation of idle assets.

From moneycontrol.com

Who's involved

Keep exploring

The entities involved

  • Alkem Laboratories

    multinational pharmaceutical company headquartered in Mumbai,

    Nothing else this week.

  • Medtech

    medical education facility founded in 2004 in Indianapolis, U.S

    Nothing else this week.

Coverage

Newest first; wire copies grouped